The long-term effectiveness of allergy immunotherapy in subjects with asthma is associated with a lower prevalence of sleep disturbances. Results from the REACT-study
M. Contoli (Ferrara, Italy), B. Fritzsching (Heidelberg, Germany), N. Freemantle (London, United Kingdom), S. Buchs (Hoersholm, Denmark), J. Larsen (Hoersholm, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Source: International Congress 2022 – Update on clinical trials in allergy, asthma and COPD
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Contoli (Ferrara, Italy), B. Fritzsching (Heidelberg, Germany), N. Freemantle (London, United Kingdom), S. Buchs (Hoersholm, Denmark), J. Larsen (Hoersholm, Denmark), C. Porsbjerg (Copenhagen, Denmark). The long-term effectiveness of allergy immunotherapy in subjects with asthma is associated with a lower prevalence of sleep disturbances. Results from the REACT-study. 3202
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|